Yuvraj

Roche announced late-breaking Phase III data showing that fenebrutinib reduces disability progression in PPMS, marking the first investigational advance for primary progressive multiple sclerosis...

Innovent Biologics has announced a strategic Innovent-Lilly partnership with Eli Lilly and Company to advance the global development of new medicines in oncology and...

Deep dive into the convergence of medical engineering and pharmaceutical science, focusing on how integrated delivery systems enhance dosing accuracy and patient outcomes.

Exploration of how computational modeling, high-throughput screening, and digital twins are revolutionizing the pharmaceutical R&D process to optimize formulation efficiency.

GSK’s new chief executive, Luke Miels, said the drugmaker will prioritise faster drug development as it enters its next phase of growth, with a...

Examination of the pharmaceutical industry's transition toward biodegradable polymers and eco-friendly excipients to reduce environmental impact while maintaining high therapeutic standards.

The UK and Japanese governments have announced a wide-ranging partnership that sees UK and Japan strengthen science and technology ties across pharmaceuticals, genomics, quantum...